Mordecai Kramer

Mordecai Kramer is the Vice President of Life Science Value & Partnerships at Health Catalyst, where responsibilities include expanding the Carevive life science business focused on improving the patient experience in cancer. Previously, Mordecai served as Vice President at Carevīve, enhancing life science partnerships and leveraging data to improve cancer patient care and outcomes. Earlier roles include Executive Director of Business Development at Baim Institute for Clinical Research, where nearly $500 million in clinical research engagements were orchestrated, and General Manager at both Cambridge Biomedical Research Group and Odyssey Therapeutics. Mordecai's educational background includes an MBA in International Business from McGill University and a BS in Accounting and Economics from Yeshiva University.